MedPath

Hi-Fatigue G Bone Cement Retrospective Study

Recruiting
Conditions
Total Hip and Knee Arthroplasties
Registration Number
NCT06699134
Lead Sponsor
Zimmer Biomet
Brief Summary

The objective of this retrospective monocentric study is to collect survivorship and clinical data confirming safety, performance and clinical benefits for the Hi-Fatigue G Bone Cement.

The assessments will include:

* Radiological analysis performed at different time points according to the standard of care of the hospital

* Implant survivorship and safety based on removal of a study device

* Patient reported outcome measures (PROMs)

Primary endpoint:

Assessment of radiolucent lines around the components (tibial, femoral, acetabular) at 5 years (in accordance with the hospital standard of care).

Secondary endpoints:

* Evaluation of implant survivorship and safety by monitoring the frequency and incidence of adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified.

* Evaluation of PROMs

* Obtain information regarding the cementing technique and handling of the cement, if available

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Subject qualified for cemented TKA or THA with a Zimmer Biomet implant
  • Subject is willing and able to give written informed consent for retrospective data collection and undergo interim and final evaluation (X-Ray & Scores completion)
  • Subject > 18 years old
Exclusion Criteria
  • Muscle wasting
  • Neuromuscular compromise in the affected limb
  • Known hypersensitivity to any of the cement constituents
  • Subjects with severe renal failure
  • Bilateral interventions
  • Subject is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, known alcohol or drug abuser, anticipated to be non-compliant)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Radiographic evaluationFrom enrollment to the 5 year post-op follow up.

Detection of radiolucent lines around the implant components (tibial, femoral, acetabular) at 5 years (in accordance with the hospital standard of care).

Secondary Outcome Measures
NameTimeMethod
SurvivorshipFrom enrollment to the 5 year post-op follow up.

Evaluation of implant survivorship and safety by monitoring the frequency and incidence of adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified.

Patient reported outcome measures (PROM)From enrollment to the 5 year post-op follow up.

Evaluation of PROMs, collected in accordance with the hospital standard of care.

Cement InformationFrom enrollment to the 5 year post-op follow up.

Obtain information regarding the cementing technique and handling of the cement, if available

Trial Locations

Locations (1)

Klinikum Weiden

🇩🇪

Weiden, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath